Novo Holdings in major deal to boost Wegovy supply | REUTERS

Novo Nordisk notched a win in its race to boost the output of its popular obesity drug Wegovy, with its parent company announcing it was buying Catalent, a key manufacturing subcontractor of the product, for $11.5 billion.
👉 Read the story here: reut.rs/49mxqQn
Keep up with the latest news from around the world: www.reuters.com/
#News #Reuters #newsfeed #novonordisk #obesity #drug
Subscribe: smarturl.it/reu...
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: www.reuters.com/
Follow Reuters on Facebook: / reuters
Follow Reuters on Twitter: / reuters
Follow Reuters on Instagram: www.instagram....